Empresa Catabasis Pharmaceuticals Inc Nasdaq
Acciones
US14875P1075
Biotecnología e investigación médica
Resumen de negocios
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Jill Milne
FOU | Founder | 56 | 26/06/08 |
Noah Clauser
DFI | Director of Finance/CFO | 51 | 01/04/11 |
Chief Tech/Sci/R&D Officer | - | 15/07/22 | |
John Ruesch
PRN | Corporate Officer/Principal | - | 17/07/23 |
Keri McGrail
HRO | Human Resources Officer | - | 01/03/21 |
Andrew Komjathy
PRN | Corporate Officer/Principal | 61 | 25/09/19 |
Ben Harshbarger
LAW | General Counsel | 55 | 12/06/20 |
Andrea Matthews
PRN | Corporate Officer/Principal | - | 01/07/14 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Ken Bate
CHM | Chairman | 73 | 01/01/14 |
Gregg Lapointe
BRD | Director/Board Member | 65 | 04/01/19 |
Director/Board Member | 75 | 05/04/16 | |
Jonathan Violin
BRD | Director/Board Member | 49 | 28/01/21 |
Jill Milne
FOU | Founder | 56 | 26/06/08 |
Hugh Cole
BRD | Director/Board Member | 59 | 26/07/19 |
Joanne Beck
BRD | Director/Board Member | 63 | 14/02/19 |
Director/Board Member | 56 | 28/01/21 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 54 913 061 | 48 159 943 ( 87,70 %) | 0 | 87,70 % |
Acción B | 0 | 31 107 | 0 | 0 |
Información de la empresa
Sector
Varia. 1 de ene. | Capi. | |
---|---|---|
+8,63 % | 115 mil M | |
+13,17 % | 107 mil M | |
-12,76 % | 22,31 mil M | |
-3,99 % | 21,6 mil M | |
-7,19 % | 18,23 mil M | |
-39,93 % | 17,62 mil M | |
+6,67 % | 14,26 mil M | |
+33,90 % | 12,37 mil M | |
-28,60 % | 8281,14 M |